Inspira Technologies Oxy BHN (IINN) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Inspira Technologies Oxy BHN has unveiled the INSPIRA Cardi-ART, a groundbreaking portable device designed to deliver oxygen to the brain during cardiac arrest situations, which could significantly improve survival rates. With the potential to target a combined global market worth $58.8 billion, the company plans to seek FDA approval by 2026. The device, currently in development, aims to leverage Inspira’s advanced blood oxygenation and monitoring technologies to offer lifesaving support for cardiac arrest patients both in and outside hospitals.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.